Back

Association of CYP2C19*2 and PEAR1 gene variant with platelet reactivity and clinical outcomes in patients undergoing stenting and treated with aspirin and clopidogrel

28 August 2018 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 6 - Pharmacogenetics - New sights on the horizon Pharmacogenetics ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Ke Xu

Shanghai Chest Hospital, Shanghai (China)

5 More presentations in this session

Presentation thumbnail
Doctor A. Franci (Sao Paulo, BR)
Abstract Slides
Presentation thumbnail
Doctor L. Gross (Munich, DE)
Abstract Slides
Presentation thumbnail
Doctor S. Kim (Busan, KR)
Abstract Slides
Presentation thumbnail
Mrs R. Olie (Maastricht, NL)
Abstract
Presentation thumbnail
Doctor J. Li (Busan, KR)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 6 - Pharmacogenetics - New sights on the horizon

The Event

Event poster

ESC Congress 2018

28 August 2018 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Impact of clopidogrel metabolizer status on platelet aggregation and association with outcomes in AF patients undergoing PCI
30 August 2025
thumbnail
Congress Presentation
Platelet-endothelial aggregation receptor 1 inhibits reendothelialization of injured arteries
25 April 2024
thumbnail
Congress Presentation
Impact of platelet reactivity on subclinical valve thrombosis in patients treated with TAVR
26 August 2023
thumbnail
Congress Presentation
Assessment of the antiplatelet effect of different p2y12 inhibitors using two methods at 30 and 120 minutes after oral loading in the cardiac catheterization laboratory
21 March 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources